These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5477945)

  • 1. The treatment of congenital adrenal hyperplasia with aminoglutethimide.
    Hamilton W; Moodie T
    Dev Med Child Neurol; 1970 Oct; 12(5):618-28. PubMed ID: 5477945
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of congenital adrenal hyperplasia with aminoglutethimide.
    Hamilton W
    Q J Med; 1971 Oct; 40(160):568-9. PubMed ID: 5157412
    [No Abstract]   [Full Text] [Related]  

  • 3. Aminoglutethimide: a "side-effect" turned to therapeutic advantage.
    Hughss SW; Burley DM
    Postgrad Med J; 1970 Jul; 46(537):409-16. PubMed ID: 4920933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid composition of the sterol ester fraction of human adrenal cortex in Cushingś syndrome and after treatment with aminoglutethimide.
    Raggatt PR; Engel LL; Symington T
    Lipids; 1972 Jul; 7(7):474-82. PubMed ID: 5049143
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of eliptene aminoglutethimide on the excretion of gonadotropins and phenol steroids (preliminary study)].
    Dil'man VM; Krylova NV; Tsyrlina EV; Vishnevskiĭ AS
    Vopr Onkol; 1969; 15(3):94-5. PubMed ID: 5406696
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with aminoglutethimide (Elipten), a new inhibitor of steroid biosynthesis in the adrenal gland].
    Horký K; Küchel O; Gregorová I; Jiránková J; Matys Z
    Schweiz Med Wochenschr; 1968 Nov; 98(47):1843-51. PubMed ID: 4236505
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].
    Philbert M; Laudat MH; Laudat P; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(2):189-210. PubMed ID: 4298418
    [No Abstract]   [Full Text] [Related]  

  • 8. Qualitative alterations in urinary 17-ketosteroid excretion during aminoglutethimide administration.
    Horký K; Küchel O; Gregorvá I; Stárka L
    J Clin Endocrinol Metab; 1969 Feb; 29(2):297-9. PubMed ID: 4236926
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical aminoglutethimide and sebum excretion.
    Burton JL; Cartlidge M; Shuster S
    Br J Dermatol; 1971 Oct; 85(4):400-1. PubMed ID: 4256642
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of Cushing's disease treated by aminoglutethimide].
    Thevenet M; Lumbroso P; Netter A
    Ann Endocrinol (Paris); 1968; 29(3):346-50. PubMed ID: 4326387
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluctuating Cushing's syndrome, acute psychosis, aminoglutethimide therapy.
    Barnett IG; Nabarro JD; LeQuesne LP
    Proc R Soc Med; 1970 Apr; 63(4):338-9. PubMed ID: 5441960
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of elipten in Itsenko-Cushing disease (preliminary report)].
    Marova EI; Lemesheva SN
    Probl Endokrinol (Mosk); 1970; 16(5):7-10. PubMed ID: 5520275
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of aminoglutethimide and reserpine on the human pituitary-adrenal axis: remission of a case of Cushing's disease.
    Givens JR; Camacho A; Patterson P
    Metabolism; 1970 Oct; 19(10):818-30. PubMed ID: 4918596
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of amino-glutethimide in the ectopic ACTH syndrome.
    Gorden P; Becker CE; Levey GS; Roth J
    J Clin Endocrinol Metab; 1968 Jun; 28(6):921-3. PubMed ID: 4172920
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of aminoglutethimide in a case of ectopic ACTH syndrome. Influence on steroid metabolism.
    McMillan M; Maisey MN
    Acta Endocrinol (Copenh); 1970 Aug; 64(4):676-86. PubMed ID: 4318105
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of O,p'DDD and aminoglutethimide on metastatic adrenocortical carcinoma.
    Bochner F; Lloyd HM; Roeser HP; Thomas MJ
    Med J Aust; 1969 Apr; 1(16):809-12. PubMed ID: 5769733
    [No Abstract]   [Full Text] [Related]  

  • 17. Iatrogenic hypertension in children with congenital adrenal hyperplasia.
    Kirkland JL; Kirkland RT; Librik L; Clayton GW
    J Pediatr; 1973 Oct; 83(4):687-9. PubMed ID: 4729999
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reduced excretion of total gonadotropins during use of Elipten in breast neoplasms].
    Eliubaeva GO; Sanchakova AV; Vishnevskiĭ AS; Dil'man VM
    Vopr Onkol; 1972; 18(3):92-3. PubMed ID: 5017847
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypertension secondary to excessive desoxycorticosterone implants or 9-alpha fluorocortisol in salt-losing congenital adrenal hyperplasia.
    Vazquez AM; Kenny FM
    J Pediatr; 1972 Sep; 81(3):549-52. PubMed ID: 5049827
    [No Abstract]   [Full Text] [Related]  

  • 20. Amino-glutethimide (elipten) in adenocortical carcinoma.
    Miranda-Zetterstrand N; Díaz-Bonet L; Pagán-Sáez H; Rosaly de Jirau W
    Bol Asoc Med P R; 1968 Dec; 60(12):611-8. PubMed ID: 5253414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.